Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Nakeff

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 26, 2013
Marylou Ingram, M.D. (1920-2013)Alexander Nakeff, Carleton C Stewart
Cytometry|January 5, 2002
Painting with a molecular brush: genomic/proteomic interfacing to define the drug action profile of novel solid-tumor selective anticancer agentsAlexander Nakeff, Nisha Sahay, Mike Pisano, et al.
Journal of Experimental Therapeutics & Oncology|November 6, 2002
Cellular drug action profile paradigm applied to XK469Balanehru Subramanian, Alexander Nakeff, Joseph Media, et al.
Journal of Experimental Therapeutics & Oncology|March 15, 2006
A new paradigm for the development of anticancer agents from natural productsBalanehru Subramanian, Alexander Nakeff, Karen Tenney, et al.
Anti-Cancer Drugs|November 20, 2002
Inhibition of macromolecular synthesis by cryptophycin-52Balanehru Subramanian, Alexander Nakeff, Joseph E Media, et al.
International Journal of Cancer|January 5, 2002
Mitotic arrest induced by XK469, a novel antitumor agent, is correlated with the inhibition of cyclin B1 ubiquitinationHong Lin, Xiang Y Liu, Balanehru Subramanian, et al.
Neuro-Oncology|October 21, 2003
SPARC affects glioma cell growth differently when grown on brain ECM proteins in vitro under standard versus reduced-serum stress conditionsSatya V Vadlamuri, Joe Media, Steadman S Sankey, et al.
Analytical Chemistry|August 16, 2003
A comparison of drug-treated and untreated HCT-116 human colon adenocarcinoma cells using a 2-D liquid separation mapping method based upon chromatofocusing PI fractionationFang Yan, Balanehru Subramanian, Alexander Nakeff, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 26, 2013
Marylou Ingram, M.D. (1920-2013)Alexander Nakeff, Carleton C Stewart
Cytometry|January 5, 2002
Painting with a molecular brush: genomic/proteomic interfacing to define the drug action profile of novel solid-tumor selective anticancer agentsAlexander Nakeff, Nisha Sahay, Mike Pisano, et al.
Journal of Experimental Therapeutics & Oncology|November 6, 2002
Cellular drug action profile paradigm applied to XK469Balanehru Subramanian, Alexander Nakeff, Joseph Media, et al.
Journal of Experimental Therapeutics & Oncology|March 15, 2006
A new paradigm for the development of anticancer agents from natural productsBalanehru Subramanian, Alexander Nakeff, Karen Tenney, et al.
Anti-Cancer Drugs|November 20, 2002
Inhibition of macromolecular synthesis by cryptophycin-52Balanehru Subramanian, Alexander Nakeff, Joseph E Media, et al.
International Journal of Cancer|January 5, 2002
Mitotic arrest induced by XK469, a novel antitumor agent, is correlated with the inhibition of cyclin B1 ubiquitinationHong Lin, Xiang Y Liu, Balanehru Subramanian, et al.
Neuro-Oncology|October 21, 2003
SPARC affects glioma cell growth differently when grown on brain ECM proteins in vitro under standard versus reduced-serum stress conditionsSatya V Vadlamuri, Joe Media, Steadman S Sankey, et al.
Analytical Chemistry|August 16, 2003
A comparison of drug-treated and untreated HCT-116 human colon adenocarcinoma cells using a 2-D liquid separation mapping method based upon chromatofocusing PI fractionationFang Yan, Balanehru Subramanian, Alexander Nakeff, et al.
Pageof 1